(Q35917696)

11 August 2017

1 reference

title

Management of hepatitis C virus genotype 4. (English)

1 reference

11 August 2017

1 reference

1 reference

1

Ayman A Abdo

1 reference

11 August 2017

Samuel S Lee

2

1 reference

11 August 2017

publication date

1 November 2004

1 reference

Journal of Gastroenterology and Hepatology

11 August 2017

published in

1 reference

11 August 2017

volume

19

1 reference

11 August 2017

issue

11

1 reference

11 August 2017

page(s)

1233-1239

1 reference

Hepatitis C virus infection

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Course and outcome of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Asian perspectives on viral hepatitis: hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Genetic epidemiology of hepatitis C virus throughout egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Hepatitis C genotypes and subtypes in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Treatment of hepatitis C virus genotype 4-related cirrhosis: ribavirin and interferon combination compared with interferon alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Improved response to ribavirin interferon combination compared with interferon alone in patients with type 4 chronic hepatitis C without cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Hepatitis-C-virus genotypes and hepatitis-G-virus infection in Lebanese thalassaemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Genotypes of hepatitis C virus in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Prevalence and characterization of hepatitis C virus genotype 4 in Japanese hepatitis C carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Prevalence of hepatitis C virus genotypes in southern Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Changes in the prevalence of hepatitis C virus (HCV) genotype 4 in Calabria, Southern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Route of infection, liver histology and response to interferon in patients with chronic hepatitis caused by genotype 4 HCV infection in a Western country

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Treatment of chronic hepatitis C genotype IV with interferon-ribavirin combination in Saudi Arabia: a multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Hepatitis C virus genotype 4 and response to combination therapy with interferon-alpha2b plus ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2003.03325.X

10.1111/J.1440-1746.2003.03325.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference